| h-be723cd406 | Selectively Inhibit Maladaptive AQP4-Driven Astrocyte-Microglia Inflammatory Sig | 0.50 | 0.45 | AQP4, NFKB1, IL1B, TNF | proposed | 2026-04-21 | SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2 |
| h-c92fabed93 | Shift AQP4 Isoform/OAP Assembly Toward Clearance-Competent Autoantibody-Less-Clu | 0.50 | 0.48 | AQP4-M1, AQP4-M23 | proposed | 2026-04-21 | SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2 |
| h-4898d2a838 | Autophagy-Lysosomal Flux Impairment Preventing Pathological TDP-43 Clearance | 0.50 | 0.48 | TFEB, LAMP1, LAMP2, GABARAPL1, CTSD | proposed | 2026-04-21 | SDA-2026-04-07-gap-pubmed-20260406-062202-c8c5a9a1 |
| h-0cc354f674 | Nuclear Pore and Nucleocytoplasmic Transport Machinery as Gatekeepers | 0.50 | 0.48 | NXF1, NXT1, XPO1, KPNA, RAN | proposed | 2026-04-21 | SDA-2026-04-07-gap-pubmed-20260406-041428-53b81741 |
| h-a74317ce69 | LRP1 Loss-of-Function Derepresses P2RY12 Expression | 0.50 | 0.50 | LRP1 | proposed | 2026-04-21 | SDA-2026-04-07-gap-pubmed-20260406-041434-a4d6154a |
| h-b2fd6e79d1 | Nucleolar p21-rRNA Co-Aggregation as Irreversible Senescence Gate | 0.50 | 0.48 | NCL, FBL, AMBRA1, CDKN1A | proposed | 2026-04-21 | SDA-2026-04-07-gap-debate-20260406-062101-724971bc |
| h-92a91b35a0 | NETosis Amplification by C1Q in Plaque Neutrophils | 0.50 | 0.45 | C1QA/C1QC | proposed | 2026-04-21 | SDA-2026-04-07-gap-pubmed-20260406-062122-b65f8ebc |
| h-f5d32997 | SIRT1-Mediated Epigenetic Restoration of MFSD2A Expression Re-enables SPM Precur | 0.50 | 0.50 | MFSD2A / SIRT1 (deacetylase activator axis) | proposed | 2026-04-13 | SDA-2026-04-12-gap-debate-20260410-113110-2059f65f |
| h-d9c5a529 | Alectinib-C1q Complex Hijacks TREM2's Synaptic Protective Binding Interface | 0.50 | 0.45 | C1QA/C1QB/C1QC, TREM2 | proposed | 2026-04-17 | SDA-2026-04-16-gap-pubmed-20260410-095709-4e97c09e |
| h-1e2405e1 | Cholinergic Attention Modulation Hypothesis | 0.50 | 0.40 | CHRNA7 | archived | 2026-04-12 | SDA-2026-04-04-gap-debate-20260403-222510-20260402 |
| h-var-7b5e9a60eb | TREM2-Mediated Microglial Dysfunction Drives Tau-Induced Blood-Brain Barrier Bre | 0.50 | 0.67 | TREM2 | proposed | 2026-04-21 | SDA-2026-04-03-26abc5e5f9f2 |
| h-var-be69d8af79 | TBK1 Loss Drives Microglial Senescence-SASP to Generate MMP-9-Mediated TDP-43 C- | 0.50 | 0.34 | TBK1 | proposed | 2026-04-27 | SDA-2026-04-26-gap-20260425215446 |
| h-var-75cc30ad27 | Astrocytic Complement Regulator Secretion Modulates Synaptic Vulnerability (CD55 | 0.50 | 0.33 | CD55 (DAF), CD46 (MCP) | proposed | 2026-04-27 | SDA-2026-04-07-gap-pubmed-20260406-062128-c84a87d9 |
| h-var-244d3d8d08 | LDLR-Targeted Anti-Inflammatory Antibody Delivery for Neuroinflammation Suppress | 0.50 | 0.53 | LDLR | proposed | 2026-04-27 | SDA-2026-04-12-gap-debate-20260410-112908-13c403ee |
| h-c86acecdaa | Neurogranulin Predicts p-tau217 Reliability by Identifying Patients with Intact | 0.50 | 0.42 | NRGN | proposed | 2026-04-25 | |
| h-df4e435ebf | RNA-binding proteins stabilize or gate the lncRNA-0021:mmu-miR-6361 duplex | 0.50 | 0.39 | TARDBP/FUS/HNRNPA2B1 | proposed | 2026-04-26 | SDA-2026-04-26-gap-pubmed-20260410-150509-76c40dac-debate |
| h-var-3d720b9066 | Aggregation-prone sequences trigger HSP90-dependent conformational triage throug | 0.50 | 0.35 | HSP90AA1, HSP90AB1, CDC37, AKT1 | proposed | 2026-04-27 | SDA-2026-04-10-gap-debate-20260410-075012-32bac138 |
| h-a11f71b5 | Conditional CRISPR Kill Switches for Aberrant Protein Clearance | 0.50 | 0.30 | UBE3A, PARK2, PINK1 | archived | 2026-04-04 | SDA-2026-04-03-gap-crispr-neurodegeneration-20260402 |
| h-130ad9483e | TREM2 on Perivascular Macrophages Senses Aβ and Drives SPP1 Upregulation Through | 0.50 | 0.48 | SPP1 | proposed | 2026-04-22 | SDA-2026-04-06-gap-pubmed-20260406-062118-5e49e14f |
| h-ed41a306c5 | VDAC1 Hyper-Oligomerization via Direct TDP-43 Binding | 0.50 | 0.45 | VDAC1, VDAC2 | proposed | 2026-04-21 | SDA-2026-04-08-gap-pubmed-20260406-062141-739c7f1c |
| h-var-80a3b3dd52 | Temporal NLRP3 Inhibition via SPP1-Mediated Mitophagy Enhancement During Critica | 0.50 | 0.39 | NLRP3 | promoted | 2026-04-21 | SDA-2026-04-15-gap-pubmed-20260406-062118-e3613755 |
| h-var-f19f044a9a | TREM2-Mediated Microglial Metabolic Reprogramming Accelerates Tau Pathological S | 0.49 | 0.67 | TREM2 | proposed | 2026-04-21 | SDA-2026-04-03-26abc5e5f9f2 |
| h-b97e6bb5f1 | Lamin B1 Degradation as Irreversibility Gate | 0.49 | 0.52 | LMNB1, LMNB2, NCOA4, SQSTM1 | proposed | 2026-04-21 | SDA-2026-04-07-gap-debate-20260406-062101-724971bc |
| h-f11788656b | YAP/TAZ Mechanosensing Cooperates with NF-κB to Amplify SPP1 Transcription in Pe | 0.49 | 0.42 | SPP1 | proposed | 2026-04-22 | SDA-2026-04-06-gap-pubmed-20260406-062118-5e49e14f |
| h-var-bee1a6239c | GluN2B-Regulated Microglial Phagocytosis of Tau Aggregates via CX3CR1 Signaling | 0.49 | 0.67 | GRIN2B | proposed | 2026-04-21 | SDA-2026-04-03-26abc5e5f9f2 |
| h-6b489d1dee | Autophagy Enhancement via mTOR Inhibition for C9orf72 Dipeptide Repeat Pathology | 0.49 | 0.55 | MTOR/C9orf72 | proposed | 2026-04-29 | SDA-2026-04-28-gap-test-20260425-224949 |
| h-f9e4985929 | Tumor-derived extracellular vesicles as TREM2 ligands | 0.49 | 0.45 | TREM2 ligands on tumor EVs | proposed | 2026-04-26 | SDA-2026-04-26-gap-pubmed-20260410-150544-e3a2eab9-debate |
| h-a0bd8d4f4c | Reactive astrocyte glutamate-handling failure sustains dendritic tau-associated | 0.49 | 0.47 | SLC1A2,GRIN2B,MAPT | proposed | 2026-04-25 | SDA-2026-04-25-gapdebate-98a600b3ed |
| h-588406cca9 | G3BP1-TDP-43 Cross-Seeding Drives Co-Aggregation That Prion-Spreads Across Neura | 0.49 | 0.52 | TARDBP | proposed | 2026-04-22 | SDA-2026-04-06-gap-pubmed-20260406-041428-e14e6524 |
| h-6be018d35a | Testosterone-Derived DHT Amplifies Microglial Androgen Receptor Signaling Drivin | 0.49 | 0.52 | AR | proposed | 2026-04-22 | SDA-2026-04-06-gap-pubmed-20260406-041439-ec89b1e4 |
| h-373fac84b5 | P2RY12/P2RY13 Purinergic Receptor Metabolic Rewiring | 0.49 | 0.48 | P2RY12, P2RY13, CTNNB1 (β-catenin), GSK3β | proposed | 2026-04-22 | SDA-2026-04-06-gap-pubmed-20260406-062118-e3613755 |
| h-c40be3e018 | OPA1-Mediated Cristae Architecture Vulnerability | 0.49 | 0.48 | OPA1, MFN1/2, DRP1 (DNM1L), mitochondrial protease cleavage | proposed | 2026-04-21 | SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046 |
| h-23cba4e15d | Targeting AQP4 Sumoylation to Enhance Glymphatic Clearance as Therapeutic Strate | 0.49 | 0.44 | AQP4; SENP1; SENP2; UBC9 | proposed | 2026-04-21 | SDA-2026-04-07-gap-pubmed-20260406-041445-ce0abc1e |
| h-45b0992fc4 | Mitochondrial Proteostasis Hijacking | 0.49 | 0.52 | TOMM40 | proposed | 2026-04-21 | SDA-2026-04-08-gap-pubmed-20260406-062202-5c32c50a |
| h-6f6f920e83 | Sulfated glycans and metal-binding CSF proteins brace alpha-synuclein fibril pol | 0.49 | 0.42 | SNCA | proposed | 2026-04-26 | SDA-2026-04-26-gap-pubmed-20260411-081644-1d2624b8-debate |
| h-a976bf02b0 | Structured Intronic Scaffold Regions in Enhancer-dilncRNAs Enable Cell-Type Sele | 0.49 | 0.42 | ECEPs (PAX6-AS1, KCNC2-AS1) | proposed | 2026-04-21 | SDA-2026-04-10-gap-debate-20260410-075007-232fbf62 |
| h-var-3993e74fb3 | C1q-Mediated Delivery of miR-33 Antisense Oligonucleotides for Enhanced APOE4 Li | 0.49 | 0.36 | miR-33a/miR-33b | promoted | 2026-04-20 | SDA-2026-04-16-gap-debate-20260410-113104-a13caf2e |
| h-var-8c9cecfc00 | SREBP-2 Direct Inhibition Hyper-Lipidation Strategy | 0.49 | 0.36 | SREBF2/ABCA1 | promoted | 2026-04-20 | SDA-2026-04-16-gap-debate-20260410-113104-a13caf2e |
| h-4b91b4b2d5 | Hyperphosphorylated TDP-43 Traps TRIM21 Into Inactive Complexes | 0.49 | 0.48 | TARDBP, TRIM21 | proposed | 2026-04-22 | SDA-2026-04-06-gap-pubmed-20260406-041423-3a6aa4ab |
| h-92a69aa3 | USP14 Inhibition to Accelerate Proteasomal Degradation of Synaptic Substrates | 0.49 | 0.46 | USP14 (ubiquitin-specific peptidase 14) | proposed | 2026-04-26 | SDA-2026-04-16-frontier-proteomics-1c3dba72 |
| h-3a0c21057e | Kinesin-Dependent Peripheral Microtubule Transport Maintains Receptor Exclusion | 0.49 | 0.42 | KIF5B/KIF5C | proposed | 2026-04-21 | SDA-2026-04-08-gap-pubmed-20260406-041423-9c2c2ee3 |
| h-var-73142bada1 | APOE4 Structural Remodeling via HSP70 Chaperone Enhancement Strategy | 0.49 | 0.37 | HSP70/APOE4 | promoted | 2026-04-21 | SDA-2026-04-16-gap-debate-20260410-113104-a13caf2e |
| h-2a1a95c1 | Oligodendrocyte Progenitor Cell Metabolic Reprogramming | 0.49 | 0.40 | PDK1, PFKFB3, LDHA | archived | 2026-04-04 | SDA-2026-04-03-gap-debate-20260403-222543-20260402 |
| h-SDA-2026-04-26-gap | Soluble LRP1 Fragments Serve as Blood-Based Indicators of Impaired Aβ Efflux and | 0.49 | 0.30 | LRP1 | proposed | 2026-04-26 | SDA-2026-04-26-gap-20260426-001521 |
| h-SDA-2026-04-26-gap | Plasma NfL Elevation Secondary to BBB-Associated Transport Dysfunction Enables L | 0.49 | 0.30 | NEFL | proposed | 2026-04-26 | SDA-2026-04-26-gap-20260426-001521 |
| h-a3f785df | Sonic hedgehog pathway compartmentalization as quantitative biomarker for neuron | 0.49 | 0.45 | ADCY3 (adenylate cyclase), ARL13B (ciliary targeting), GNAI1 | proposed | 2026-04-26 | SDA-2026-04-10-gap-debate-20260410-075000-7396040a |
| h-var-71a27b2aa2 | TFEB-Mediated Lysosomal Biogenesis Enhancement for NLRP3 Inflammasome Regulation | 0.48 | 0.40 | TFEB | promoted | 2026-04-21 | SDA-2026-04-03-gap-immune-atlas-neuroinflam-20260402 |
| h-var-fe9c7bfb0c | GluN2B-Mediated Perivascular Pericyte Control of Glymphatic Tau Clearance | 0.48 | 0.67 | GRIN2B | proposed | 2026-04-21 | SDA-2026-04-03-26abc5e5f9f2 |
| h-var-45ec9caaa4 | PINK1/PARK2-LC3 Mitophagy Enhancement | 0.48 | 0.40 | PINK1 | promoted | 2026-04-21 | SDA-2026-04-03-gap-immune-atlas-neuroinflam-20260402 |
| h-f86127b5 | HDAC6 Inhibition for Dual Restoration of Microtubule Stability and Autophagic Ta | 0.48 | 0.52 | HDAC6 | proposed | 2026-04-13 | SDA-2026-04-13-gap-debate-20260412-094612-a2e3bd09 |